Loading clinical trials...
Loading clinical trials...
A Phase 3, Randomized, Parallel-Group, Multi-Center, Multi-National Study for the Evaluation of Efficacy and Safety of (LMW) Heparin/Edoxaban Versus (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis (DVT) and or Pulmonary Embolism (PE).
Conditions
Interventions
edoxaban tosylate(DU-176b)
low molecular weight heparin/unfractionated heparin
+1 more
Locations
454
United States
Investigational Site 7103
Mobile, Alabama, United States
Investigational Site 7132
Montgomery, Alabama, United States
Investigational Site 7126
Phoenix, Arizona, United States
Investigational Site 7139
Little Rock, Arkansas, United States
Investigational Site 1070
Anaheim, California, United States
Investigational Site 7125
Los Alamitos, California, United States
Start Date
October 1, 2009
Primary Completion Date
April 1, 2013
Completion Date
April 1, 2013
Last Updated
March 5, 2019
NCT06189313
NCT07015905
NCT03728166
NCT07102160
NCT06393868
NCT07140523
Lead Sponsor
Daiichi Sankyo
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions